Cardiac sarcoidosis responding to monotherapy with infliximab

被引:56
作者
Uthman, Imad [1 ]
Touma, Zahi [1 ]
Khoury, Maurice [1 ]
机构
[1] Amer Univ Beirut, Ctr Med, Dept Internal Med, Fac Med, Beirut 2090, Lebanon
关键词
heart block; infliximab; sarcoidosis; tumor necrosis factor;
D O I
10.1007/s10067-007-0614-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac involvement is a rare and potentially life-threatening complication of sarcoidosis. We report the case of a young previously healthy woman who presented with complete atrioventricular heart block. Further evaluation revealed non-caseating granulomas in the hilar and mediastinal regions. A pacemaker was inserted, and she was treated with four doses of infliximab after she refused treatment with steroids. Rapid resolution of the pulmonary lymph nodes was documented and repeated interrogations of the pacemaker 1 year after her last infliximab infusion documented that she was in sinus rhythm. Infliximab may be considered as an alternative first-line therapy in sarcoidosis with serious organ involvement.
引用
收藏
页码:2001 / 2003
页数:3
相关论文
共 15 条
[1]   Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement [J].
Baughman, Robert P. ;
Drent, Marjolein ;
Kavuru, Mani ;
Judson, Marc A. ;
Costabel, Ulrich ;
du Bois, Roland ;
Albera, Carlo ;
Brutsche, Martin ;
Davis, Gerald ;
Donohue, James F. ;
Mueller-Quernheim, Joachim ;
Schlenker-Herceg, Rozsa ;
Flavin, Susan ;
Lo, Kim Hung ;
Oemar, Barry ;
Barnathan, Elliot S. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (07) :795-802
[2]  
Baughman RP, 2001, SARCOIDOSIS VASC DIF, V18, P70
[3]   Refractory neurosarcoidosis: A dramatic response to infliximab [J].
Carter, JD ;
Valeriano, J ;
Vasey, FB .
AMERICAN JOURNAL OF MEDICINE, 2004, 117 (04) :277-279
[4]   Cardiac sarcoidosis -: A retrospective study of 41 cases [J].
Chapelon-Abric, C ;
de Zuttere, D ;
Duhaut, P ;
Veyssier, P ;
Wechsler, B ;
Huong, DL ;
de Gennes, C ;
Papo, T ;
Blétry, O ;
Godeau, P ;
Piette, JC .
MEDICINE, 2004, 83 (06) :315-334
[5]   Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial [J].
Chung, ES ;
Packer, M ;
Lo, KH ;
Fasanmade, AA ;
Willerson, JT .
CIRCULATION, 2003, 107 (25) :3133-3140
[6]   Treatment of sarcoidosis with infliximab [J].
Doty, JD ;
Mazur, JE ;
Judson, MA .
CHEST, 2005, 127 (03) :1064-1071
[7]  
IWAI K, 1994, SARCOIDOSIS, V11, P26
[8]   Pulmonary sarcoidosis: Patterns of cytokine release in vitro [J].
Prior, C ;
Knight, RA ;
Herold, M ;
Ott, G ;
Spiteri, MA .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (01) :47-53
[9]   TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection [J].
Roach, DR ;
Bean, AGD ;
Demangel, C ;
France, MP ;
Briscoe, H ;
Britton, WJ .
JOURNAL OF IMMUNOLOGY, 2002, 168 (09) :4620-4627
[10]   Sarcoidosis and the heart [J].
Ralph Shabetai .
Current Treatment Options in Cardiovascular Medicine, 2000, 2 (5) :385-397